US 10010622
Factor VIII chimeric and hybrid polypeptides, and methods of use thereof
granted A61KA61K38/37A61K47/60
Quick answer
US patent 10010622 (Factor VIII chimeric and hybrid polypeptides, and methods of use thereof) held by BIOVERATIV THERAPEUTICS INC. expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOVERATIV THERAPEUTICS INC.
- Grant date
- Tue Jul 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K38/37, A61K47/60, A61K47/68, A61P